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Abstract: Poly(L-lactic acid), PLLA, a synthetic biodegradable
polyester, is widely accepted in tissue engineering. Hyaluronic
acid (HA), a natural polymer, exhibits an excellent biocompati-
bility, influences cell signaling, proliferation, and differentiation.
In this study, HA crosslinking was performed by immersion of
the polysaccharide in water–acetone mixtures containing glutar-
aldehyde (GA). The objective of this work is to produce PLLA
scaffolds with the pores coated with HA, that could be benefi-
cial for bone tissue engineering applications. PLLA tridimen-
sional scaffolds were prepared by compression molding
followed by salt leaching. After the scaffolds impregnation with
soluble HA solutions of distinct concentration, a GA-crosslink-
ing reaction followed by inactivation of the unreacted GA with
glycine was carried out. An increase on surface roughness is
shown by scanning electron microscopy (SEM) with the addi-
tion of HA. Toluidine blue staining indicates the present of sta-
ble crosslinked HA. An estimation of the HA original weight in
the hybrid scaffolds was performed using thermal gravimetric
analyses. FTIR-ATR and XPS confirmed the crosslinking reac-
tion. Preliminary in vitro cell culture studies were carried out
using a mouse lung fibroblast cell line (L929). SEM micro-
graphs of L929 showed that cells adhered well, spread actively
throughout all scaffolds, and grew favorably. A MTS test indi-
cated that cells were viable when cultured onto the surface of
all scaffolds, suggesting that the introduction of crosslinked HA
did not increase the cytotoxicity of the hybrid scaffolds. VC 2010
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INTRODUCTION
Bone is a dynamic and highly vascularized tissue that con-
tinues to remodel throughout the lifetime of an individual.
The self-healing capacity of bone is widely used for the
repair of small fractures. However, bone grafts are needed
to provide support, fill lacunae, and enhance biological
repair when the skeletal defect reaches a critical size.1–3
Tissue engineering (TE) emergence is boosted as an al-
ternative potential solution to current methodologies for tis-
sue transplantation and grafting.1,4 A key component in TE
for bone regeneration is the scaffold that serves as a tem-
plate for cell interactions and the formation of bone-extrac-
ellular matrix (ECM) to provide structural support to the
newly formed tissue.5 The ideal scaffold should provide a
suitable environment for tissue development. It should ex-
hibit suitable biocompatibility, favor cell attachment, prolif-
eration and differentiation, bone growth, and in vivo revas-
cularization. In addition, it should support osteointegration
with the host bone with an interconnected and highly po-
rous structure, and the gradual replacement of the scaffold
by newly formed bone.2,5 It should also be adaptable to an
irregular wound site and/or support mechanical loading,
with mechanical properties matching those of the target tis-
sue. Finally, it should be sterilizable without loss of proper-
ties, storable and implantable, without any detrimental
effects on surrounding tissue.2,6 Some authors argue that
the scaffold should be also designed to mimic the native
ECM environment as much as possible.6
Synthetic biodegradable polyesters, such as poly(L-lac-
tide) (PLLA), are widely accepted in TE.7–10 Although these
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materials revealed good mechanical properties, high purity,
and molecular control, convenient processing and favorable
degradation rate that match the rate of healing of damaged
tissue,6 the major drawback is its hydrophobic nature and
acidic degradation products.10–13 PLLA, however, does not
possess the necessary specific bioactive abilities to acceler-
ate the ECM secretion and regeneration of cultured cells.14
In addition, because the PLLA do not have functional
groups, other than end groups, enabling chemical modifica-
tion to change its characteristics, much progress in biomedi-
cal applications could be achieved if it were possible to
retain its beneficial properties while incorporating function-
alities promoting specific and desirable biological interac-
tions.8,14,15 Many strategies have been adopted, including a
change of the surface charge,16 increase in the surface
roughness17 and hydrophilicity,18 or the immobilization of a
biocompatible layer on the surface.19 Another approach
involves the use of natural polymers as scaffolds, since they
may promote cell adhesion due to having specific active
sites, however, associated with poor mechanical properties
and high rates of degradation.5,13 Therefore, scaffolds with
the features of both natural polymers and polyesters may
be desirable and will be advantageous if they match in cer-
tain extent those of the target tissue’s ECM.4,6,7,20,21
The use of natural materials, such as hyaluronic acid
(HA), in the production of scaffolds, can impart intrinsic sig-
nals within the structure that can enhance tissue forma-
tion.4,22 HA is a negatively charged, heavily hydrated linear
and natural occurring glycosaminoglycan, composed of b-
1,4-linked D-glucuronic acid(b-1,3)-N-acetyl-D-glucosamine
disaccharide units with a molecular size of 0.1–10 MDa.23,24
In its native state, HA is a high molecular weight polymer in
the ECM of almost all animal tissues.25 Thus, HA is consid-
ered as a space-filling, structure-stabilizing, cell coating, and
cell protective polysaccharide.25–27 HA has been shown to
have important functions in providing hydration in the ECM,
and vitally regulating embryonic development, tissue organi-
zation, wound healing, and angiogenesis, being also involved
in cell signaling, growth, and differentiation.24,26,28,29 In
addition, it has been shown that HA exhibits excellent bio-
compatibility, is non-thrombogenic, non-immunogenic, and
does not induce chronic inflammation.26,30,31 However, bio-
medical applications of HA have been hindered by its short
residence time and lack of mechanical integrity in an aque-
ous environment.23,32 HA can, therefore, be chemically deriv-
atized and crosslinked to generate biomaterials with diverse
physicochemical and mechanical properties,26 typically
involving the carboxylic acid groups and/or the hydroxyl
groups of its backbone.22,32–34 Dialdehydes are believed to
crosslink HA through formation of acetal or hemiacetal
groups on neighboring chains, with kinetic and spectroscopic
evidences indicating a prevalence of the hemiacetal. It is
assumed that glutaraldehyde (GA) forms either a hemiacetal
or an ether link with HA under acidic conditions.23,33 How-
ever, the use of GA is limited for applications that imply cell
culture, as this crosslinking agent is recognized as toxic and
often leads to cell death.35 Strategies have to be used to mini-
mize that risk and inactivate any unreacted GA.36–39 Never-
theless, due to the excess of HA over incorporated cross-
linker amounts and the fact that biologically active functional
groups are not involved in crosslinking, favorable biological
properties of the parent HA chains can be retained. If we
consider these properties and the added mechanical versatil-
ity of HA, this polysaccharide is an attractive biomaterial for
effective tissue regeneration.26
In this study, tridimensional PLLA porous hybrid scaf-
folds were coated with HA, followed by crosslinking with
GA, to produce biomimetic porous scaffolds for cortical
bone TE applications. Crosslinking was performed by
immersion of HA in water–acetone mixtures containing GA,
with increasing water/acetone ratios. PLLA tridimensional
scaffolds were prepared by compression molding followed
by salt leaching method. After the scaffolds impregnation
with soluble HA solutions of increasing concentration, a GA-
crosslinking reaction was carried out. To reduce the cytotox-
icity possibly induced by the GA, the materials were
immersed in a glycine aqueous solution to inactivate any
unreacted GA. The GA-crosslinking reaction was confirmed
by Fourier transform infrared total reflectance spectroscopy
(FTIR-ATR) and X-ray photoelectron spectroscopy (XPS)
analyses. The morphological changes, deposition, and stabil-
ity of the crosslinked HA were examined by scanning elec-
tron microscopy (SEM), toluidine blue (TB) staining, and
thermal gravimetric analysis (TGA). In addition, mechanical
properties were investigated for all scaffolds. PLLA scaffolds
were further analyzed through gravimetry to investigate po-
rosity. Preliminary in vitro cell culture studies were carried
out using a mouse lung fibroblast cell line (L929). L929
were seeded onto the PLLA and hybrid scaffolds, and their
adhesion was assessed by SEM. To screen possible cytotox-
icity an MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-
thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay was
performed after 72 h of in vitro culturing. L929 morphology
and proliferation were also qualitatively evaluated by SEM
after 72 h of in vitro culturing.
MATERIALS AND METHODS
Materials
In this study, a commercial grade poly(L-lactic acid) (PLLA)
of high stereoregularity (Cargill Dow Polymer Mn: 69,000,
Mw/Mn: 1.734) was used. Hyaluronic acid sodium salt (HA),
from Streptococcus equi, supplied as dry powder (Mw: 1.63
MDa, Fluka). GA, Glycine, Toluidine Blue O, a-MEM medium,
sodium bicarbonate (NaHCO3), and sterile phosphate buffer
saline (PBS) solution were purchased from Sigma-Aldrich.
Hydrochloric acid (HCl) and ethanol were purchased from
Panreac (Portugal) and acetone obtained from Pronolab
(Portugal). Fetal bovine serum (FBS), antibiotic-antimycotic
solution (A/B) consisting of 100 U/mL penicillin G sodium,
100 lg/mL streptomycin sulfate, and 250 ng/mL amphoter-
icin B (as Fungizone), sterile magnesium chloride-free
phosphate buffered saline (PBS) solution, and ethylenedia-
minetetraacetic acid (EDTA) were purchased from Gibco-
Invitrogen. Mouse lung fibroblast cell line (L929) was
purchased from HPA culture collections. MTS [3-(4,5-dime-
thylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
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2H-tetrazolium] was obtained from VWR. Finally, hexamethyl-
disilazane (HMDS), a chemical dryer, was purchased from Elec-
tron Microscopy Sciences.
Processing methodologies
Solvent casting. To confirm the chemical crosslinking reac-
tion, 1% HA films were prepared by solvent casting, as pre-
viously reported by Collins and Birkinshaw23 and Tomihata
and Ikada33 and afterward analyzed by Fourier transform
infrared total reflectance spectroscopy (FTIR-ATR) and X-ray
photoelectron spectroscopy (XPS). This methodology
enabled to study the crosslinking reaction without the syn-
thetic polymer interference.
Compression molding followed by salt leaching. In this
study, tridimensional PLLA cubical scaffolds were prepared
by compression molding followed by salt leaching, as
described elsewhere.11,40,41
A schematic representation of the scaffolds processing
route used in this study can be seen in Figure 1.
Powder preparation and compounding. The PLLA gran-
ules were milled using an IKA mill (IKA, UNIVERSALMU¨HLE
M20) with liquid nitrogen until obtaining a powder. The
PLLA with a particle size below 500 lm were then blended
with the sodium chloride (NaCl) particles (q ¼ 2.17 g/cm3)
with sizes in the range of 500–1000 lm. It was used a 4:1
NaCl/PLLA (w/w) ratio for each disc prepared.
The compression molding followed by particle leaching
method was based on blending together PLLA and the
leachable particles, in sufficient amounts to provide a con-
tinuous phase of the polymer and a dispersed phase of
leachable particles in the blend.
Scaffold production
To fabricate the individual components, the blend was com-
press molded in a steel cylindrical mold (60 mm diameter
and 10 mm height), using a Moore hydraulic press with 5 "
104 kg capacity. To prevent PLLA adhesion to the hot plates,
teflon membranes were used. Then, the blend was com-
pressed for exactly 7 min, at top and bottom platen temper-
ature of 180#C. To remove the trapped air bubbles, the pres-
sure was slowly raised to 1 " 104 kg and released, and this
process was repeated for five times. After that, the mold
was immediately cooled and the discs were removed from
the mold.
Leaching
The molded discs were cut to obtain cubes with 4.5 " 4.5
" 4.5 mm3. The cubes were immersed in distilled water,
which was changed every 4 h, for the period of 1 w to
remove all the salt particles. Finally, scaffolds were dried for
4 h at room temperature and placed overnight in a vacuum
woven, at 40#C, to completely remove the water.
HA coating and crosslinking
HA coating. Soluble and homogenous 0.05, 0.1, 0.5, and 1%
HA solutions, respectively, were prepared by sieving the HA
particles into milli-Q water, to expose the maximum area for
solvent interaction. This was followed by agitation, to mini-
mize shear stress and to achieve solutions with uniform vis-
cosity, at room temperature, for up to 4 days. On the basis
of a previous impregnation method to generate PLLA-based
hybrid scaffolds,20,21 the PLLA scaffolds were immersed into
each HA solution, using a vacuum accessory, followed by
drying overnight, at room temperature and under vacuum.
HA crosslinking. The HA modification was performed
through HA crosslinking with GA.23,33 The HA crosslinking
was performed as follows: (1) immersion of PLLA scaffold in
10 mL of a solution containing acetone-milli-Q water 80:20
(V/V), 0.01M HCl and 250 mM GA, for 48 h, at room tempera-
ture and under continuous agitation. The acetone prevents
the dissolution of the HA into the reaction solution, and all
the reaction vessels were sealed to prevent evaporation of the
acetone. The acetone concentration of 80% (V/V) and cross-
linker molarity was based on previously published data.23,33
With GA, crosslinking is favored by acidic conditions, thus
0.01M HCl was used as pH adjuster and catalyst; (2) immer-
sion of the scaffold in a similar solution except containing ace-
tone–water 50:50, for 48 h and under continuous agitation;
(3) after reaction, the scaffolds were thoroughly washed by
immersion in an ethanol–water 50:50 (V/V) solution23,33; and
(4) the scaffolds were subsequently immersed in a blocking
agent (0.025M glycine aqueous solution) for 1 h to inactivate
any unreacted GA.36,38,39
Characterization of the PLLA/HAx scaffolds
The final samples for characterization tests were: 1% HA
films (before and after crosslinking reaction), PLLA
FIGURE 1. Schematic representation of the processing methodology
used to obtain the PLLA/HAx hybrid scaffolds: (1) Compounding and
compression molding, (2) Salt leaching, (3) Impregnation of HA solu-
tions of different concentrations (0.05, 0.1, 0.5, and 1%), induced by
vacuum, (4) Vacuum drying, (5) Crosslinking solutions with acetone,
water, HCl, and glutaraldehyde, and (6) Washing and vacuum drying.
[Color figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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scaffolds, hybrid PLLA scaffolds coated with a HA 0.05, 0.1,
0.5, and 1% solution followed by crosslinking (PLLA/
0.05HAx, PLLA/0.1HAx, PLLA/0.5HAx, and PLLA/1HAx,
respectively).
Before cell culture assays, all scaffolds were sterilized
under ethylene oxide (EtO) atmosphere.
Morphology and porosity. The morphology of the samples,
surface, and cross section, was analyzed using a Leica Cam-
bridge S-360 scanning electron microscope (SEM) (Leica
Cambridge), at an accelerating voltage of 15 kV at different
magnifications. All specimens were pre-coated with a con-
ductive layer of sputtered gold.
The volume fraction of pores in the PLLA scaffolds, po-
rosity, was measured using gravimetric method. The sam-
ples were dried, weighted, filled with ethanol using a vac-
uum accessory, and subsequently weighted. The ethanol
was selected so that it wouldn’t swallow or degrade the
scaffolds’ material. Porosity was determined as a function of
the volume of pores and the total volume of the scaffold
using Eq. (1). The volume occupied by pores, Vpore, was
deduced from the weight difference between dry (mdry) and
wet (mwet) sample [Eq. (2)]. Thus, the volume of pores
equals the volume occupied by the absorbed ethanol:
Porosity; p ¼ Vpores=Vtotal ¼ Vpores=ðVscaffold þ VporesÞ (1)
in which Vpores and Vscaffold are determined as:
Vpores ¼ ðmwet 'mdryÞ=dethanol;Vscaffold ¼ mdry=dPLLA (2)
where dethanol is the density of ethanol, equal to 0.79 g/cm
3
and dPLLA is the density of the scaffolds’ material, PLLA,
equal to 1.25 g/cm3.42,43
For each sample, at least three measurements were car-
ried out and the obtained values were averaged.
HA crosslinking reaction: Qualitative and
quantitative analyses
Stereomicroscopy: Toluidine blue staining. The different
scaffolds were immersed in a 1% TB solution for 3 min,
and then thoroughly washed with distilled water. Two dif-
ferent analyses were performed: (1) to the different scaf-
folds after the crosslinking reaction and washing procedure;
and (2) to the different scaffolds after the crosslinking reac-
tion, washing procedure, and subsequent 14 days of immer-
sion in distilled water. Stereomicroscopy images were taken
from the surface of the different scaffolds, at magnitudes of
5" and 6.4", using a Stereomicroscope (Zeiss Stemi 1000
PG-HITEC).
Thermal gravimetric analysis. Thermal gravimetric analy-
ses (TGA Q500 V6.5 Build 196) were made to HAx, PLLA,
PLLA/0.05HAx, PLLA/0.1HAx, PLLA/0.5HAx, and PLLA/
1HAx samples. Samples were placed on the balance and the
temperature was raised from 30 to 1000#C, at a heating
rate of 20#C/min. The balance purge flow was of 40 mL/
min and sample purge flow, of liquid nitrogen, was of
60 mL/min. The mass of the sample pan was continuously
monitored as a function of temperature.
Fourier transform infrared total reflectance spectrosco-
py. The crosslinking reaction was investigated by FTIR-ATR
in the 1% HA and HAx films. The infrared spectra was
recorded on a spectrophotometer (IR-Prestige-21, Shimadzu,
Japan), controlled by IRsolution software. The spectra were
averaged on 32 scans in the range of 600–4400 cm'1 with
a resolution of 4 cm'1.
X-ray photoelectron spectroscopy. The XPS analyses to the
1% HA and HAx films were performed using a VG Escalab
250 iXL ESCA instrument (VG Scientific) equipped with a
monochromatic Al (Ka) X-ray source operating at 1486.92
eV. Because of the non conductive nature of the samples it
was necessary to use an electron flood gun to minimize sur-
face charging. Neutralization of the surface charge was per-
formed using both a low energy flood gun (electrons in the
range of 0–14 eV) and an electrically grounded stain steel
screen placed directly on the sample surface. The measure-
ments were carried out at a take-off angle of 90# (normal to
the surface). The measurement was performed in a Constant
Analyzer Energy mode (CAE) with 100 eV pass energy for
survey spectra and 20 eV pass energy for high resolution
spectra. Using the standard Scofield photoemission cross
sections, surface elemental composition was determined.
Overlapping peaks were resolved into their individual com-
ponents by XPSPEAK 4.1 software.
Mechanical analysis: Compression test. Uniaxial compres-
sion tests were performed on cubic scaffolds using a Univer-
sal tensile testing machine (Instron 5540 Universal
Machine) with a 1 kN load cell. Cubical scaffolds ((5 mm of
edge) were compressed at room temperature using a cross-
head speed of 2 mm/min. The test was stop when 60% of
strain was reached. The values reported are the average of
at least five specimens per condition. The compressive mod-
ulus was determined in the most linear region of the
stress–strain graph. A two-tailed, two-sample Student’s t-
test assuming unequal variances was performed to the
results.
In vitro cell culture studies
To assess the effect of the different crosslinked HA coatings,
especially the result of the use of GA as a crosslinking agent,
a MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium] preliminary cyto-
toxicity assay was performed. Cell adhesion, morphology,
and proliferation were also assessed by SEM, after 24 and
72 h. For the present studies, mouse lung fibroblast cell line
(L929) was selected for use in the cell culture studies.
L929 culturing/expansion and seeding. L929 were
replated into a T150 cm2 culture flask and then expanded
in the presence of a-MEM medium with 10% FBS and 1%
A/B, at 37#C in a 5% CO2 incubator. After reaching conflu-
ency, the cells (passage 12 and 13, P12 and P13) were
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released from substratum with 0.05% tripsin-0.53 mM
EDTA and centrifuged at 900 rpm for 10 min. Cells were
resuspended in culture media, counted and 2 " 104 and
1 " 105 cell suspensions prepared (P13, P14). The culture
medium was changed every 2 days for removal of non-
adherent cells.
Before L929 seeding, all scaffolds were pretreated (deai-
ration) to remove air bubble from the pores. Scaffolds were
placed in 10 mL polystyrene tubes with ventilation cap. Cul-
ture media was added and scaffolds were deaired under
vacuum using a 60 mL syringe with an attached 18G nee-
dle.44 Then, each scaffold was transferred into the respec-
tive well of a non-treated 24-well tissue culture polystyrene
(TCPS, Greiner Bio-One) plate.
After expansion, L929 (P13 and P14) were seeded onto
the surface of the scaffolds (PLLA, PLLA/0.05HAx, PLLA/
0.1HAx, PLLA/0.5HAx, and PLLA/1HAx), in a drop wise
manner, at the cell densities of 2 " 104 and 1 " 105 cells/
scaffold and cultured in a-MEM medium under static condi-
tions, for 24 and 72 h. Culture media were changed after
2 days and triplicates of each type of scaffold were used. A
TCPS control, for each cell concentration and time of culture
were used.
L929 adhesion, morphology, and assessment of cytotoxi-
city. L929 adhesion and morphology were also investigated
by scanning electron microscopy (SEM) analysis, after 24
and 72 h of culturing, for the seeding cell density of 1 "
105 cells/scaffold. For this purpose, after each culturing pe-
riod, samples were removed from culture, carefully washed
in Mg/Ca free PBS solution, fixed with a 2.5% glutaralde-
hyde solution in the PBS and rinsed two times with the
PBS. Afterwards, the samples were dehydrated in a series of
ethanol concentrations (40, 50, 60, 70, 80, 90, and 100%)
and chemically dried with hexamethyldisilazane (HMDS).
The samples were then sputter coated with gold before
SEM observation.
The cytotoxicity of the different scaffolds was deter-
mined by carrying out an MTS [3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium] assay, directly on the scaffolds, after 72 h, using a
L929 cell line, for the seeding cell densities of 2 " 104
and 1 " 105 cells/scaffold. For this purpose, scaffold/
L929 cells constructs were transferred into a 24-well
plate and washed with sterile PBS. Culture medium with-
out FBS and without phenol red was mixed with MTS in a
5:1 ratio, added to the wells, until totally cover the con-
structs, and incubated for 3 h at 37#C in a 5% CO2 incuba-
tor. After the incubation period, 100 mL of the MTS and
medium mixture were transferred into each well of a 96-
well TCPS plate and absorbance was read at 490 nm.45 A
two-tailed, two-sample Student’s t-test assuming unequal
variances was performed to the results.
RESULTS AND DISCUSSION
Morphology and porosity
Several manufacturing techniques have been developed to
produce porous structures aimed at being used in TE.7,13
Many of such methods use organic solvents that may lead
to residual harmful substances upon processing for the
transplanted cells or nearby tissues.41 In this work, the scaf-
folds were produced by compression molding followed by
particulate leaching in aqueous medium. Such method was
previously described by Lee et al.,46 and is adequate to pro-
duce a porous structure without the use of organic solvent.
This process is a straightforward, convenient method of fab-
ricating porous scaffolds. As represented in Figure 2, it only
requires PLLA and NaCl particles, and a compressing appa-
ratus for achieving the correct PLLA-NaCl composite struc-
ture at an adequate temperature for connecting the PLLA
particles without degrading them.46 The compression mold-
ing, particle leaching technique, gives rise to structures con-
sisting in an open network of pores throughout the sample,
which is very important for cell seeding and in-growth.41
With this technique, it is possible to control the percentage
of porosity and the pore size by varying the amount and
size of the leachable particles.41,47
For TE applications, it is important to ensure that the
scaffold has an adequate architecture to balance the integ-
rity, nutrient, and growth factor supply and cellular inva-
sion.47,48 This balance is regulated by the pore size, poros-
ity, and pore orientation within the scaffold.48 From Figure
2, it can be observed that the PLLA scaffolds morphology it
is as expected taking into consideration the size of the NaCl
particles used. Moreover, some interconnectivity is observed
indicating that the amount of NaCl particles used was
adequate. Note that one could increase the interconnectivity
of such scaffolds by using a second porogen.11 In fact, inter-
connected pores are necessary for bone tissue formation as
a mean to mimic the bone trabecular structure, and because
they allow cell migration and proliferation, as well as
vascularization.5
The porosity of the PLLA scaffolds, determined by gra-
vimetry, is of 68% 6 5%. However, the porosity of the scaf-
folds can be further augmented as desired with the addition
of higher fraction of salt. On the other hand, the size of the
scaffolds’ pores could be altered by changing the size of
the leachable particles. For that, it is important to consider
the following premises: (1) in general, the compromise in
mechanical properties of the scaffold with increasing poros-
ity sets an upper limit in terms of how much porosity and
the pore size that can be tolerated5 and (2) the microporos-
ity (pores <10 lm) contributes to the biological (cell-mate-
rial interactions) and physicochemical properties (resorp-
tion and mechanical resilience) of the material. The
macropores (pores >50 lm) should also be interconnected
to allow cell penetration into deeper layers, vascular inva-
sion, and matrix dissolution. The estimated optimal sizes
are in the range of 150–500 lm for macropores4 and >40
lm for macropore interconnections.2,5,48 However, it is well
accepted that for bone TE purposes pore size should be
within the 200–900 lm range.10
SEM micrographs on PLLA and PLLA/HAx hybrid scaf-
folds surface also showed an obvious difference in surface
morphology (Fig. 2). Similar textures are observed in the
scaffolds cross section (data not shown). This topography
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change was attributed to the following: when HA and GA
complex solution was added to the PLLA scaffolds surface,
precipitation can occur, resulting in HAx coatings. The HAx
coating is not homogeneous but the polysaccharide fraction
seems to be organized into extended structures onto the
surface of the pores of the PLLA scaffold, increasing its
roughness [Fig. 2(b–e)], although without pore obstruc-
tions.6,49,50 Surface roughness is expected to enhance attach-
ment, proliferation, and differentiation of anchorage depend-
ent bone forming cells.5
HA crosslinking reaction: Qualitative and
quantitative analyses
Stereomicroscopy: Toluidine blue staining. TB dye form
complexes with anionic glycoconjugates, such as proteogly-
cans and glycosaminoglycans, and constitute a way to iden-
tify such macromolecules.51,52 The presence of HA in the
PLLA scaffolds was investigated by performing a TB stain-
ing. The TB stain qualitatively proves if after the crosslink-
ing reaction and washing procedure, the HA remains in the
scaffolds. Moreover, the stability of the HAx coating was
investigated by immersing the scaffolds in water for 14
days, after the crosslinking reaction, followed by a washing
procedure, and subsequent analysis of the presence of HA
in the PLLA scaffolds. Figure 3(a) depicts stereomicroscopy
images of the surface of the PLLA scaffolds after 0 days,
that is, after the crosslinking reaction and washing proce-
dure, where no staining is observed. It is also possible to
observe the stereomicroscopy images of the surface of the
PLLA/HAx scaffolds [Fig. 3(b–e)], after the crosslinking
reaction, washing procedure and subsequent immersion of
the scaffolds in water, for 14 days, where the staining seems
to increase with the increase of HA content. The inserted
images illustrate stereomicroscopy images of the surface of
the PLLA/HAx scaffolds after 0 days. The simple HA coating
is not eliminated through immersion in water, and therefore,
it is a good indication of the success of the crosslinking
reaction.
Thermal gravimetric analysis. Thermogravimetric analysis
was performed to all types of materials in study: HAx,
PLLA, PLLA/0.05HAx, PLLA/0.1HAx, PLLA/0.5HAx, and
PLLA/1HAx, to determine changes in weight as a function
of temperature. GA replaces part of the hydroxyl groups,
and the crosslinking causes a change in the polymer
FIGURE 2. SEM micrographs of the surface of the developed scaffolds. (a) PLLA, (b) PLLA/0.05HAx, (c) PLLA/0.1HAx, (d) PLLA/0.5HAx, and (e)
PLLA/1HAx. In the inserted low magnified images it is possible to have a better overall perspective of the pore sizes and interconnectivity of the
scaffolds.
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structure. These physicochemical changes are reflected in
the thermal behavior of the distinct materials.53,54
Figure 4 represents part of the TGA scan of all the mate-
rials in study. The differences between the distinct materials
are clearly shown, and an analysis was done for the particu-
lar temperature of 600#C. Between 800#C and 1000#C, it is
possible to observe a progressive weight decrease due to
that residual HA. This result is a good evidence that the re-
sidual weight at 600#C is HA.
On the basis of the TGA results, an estimation of the
HAx original weight in the hybrid scaffolds was performed
through the following rationale: at 600#C, 30% of the origi-
nal HAx remains in the HAx sample and the residual weight
of the PLLA sample is negligible. At 600#C, if the residual
weight of the hybrid sample is wr, the original HA mass on
the referred scaffolds is wr/0.3. Table I shows determined
values. As expected, the content of HA in the scaffold
increases with the HA concentration of the solution used to
impregnate the PLLA scaffolds.
Fourier transform infrared total reflectance spectroscopy.
IR spectroscopy measurements were performed on 1% HA
films, before and after crosslinking reaction (Fig. 5), to
identify the bonds responsible for the HA crosslinking with
GA.
By analyzing the FTIR spectra of Figure 5(a), it is possi-
ble to observe a characteristic peak of the HA sodium salt:
the AOH and ANH bond stretching (st) vibration at 2993–
3716 cm'1, derived from the hydroxyl and secondary car-
boxylic acid amide bonds, respectively. It is also possible to
observe the C¼O (st) of carbonyl groups at 1604 cm'1,
symmetric (st) of carboxylate salts at 1410 cm'1, CAOAC
(st) symmetric ester band at 1030 cm'1, the alkane ACH
(st) bond at 2917 cm'1, and the HA aromatic groups at
FIGURE 3. Stereomicroscopy images of the surface of the developed scaffolds after immersion on a TB dye: (a) PLLA, 0 days, (b) PLLA/0.05HAx,
14 days, (c) PLLA/0.1HAx, 14 days, (d) PLLA/0.5HAx, 14 days, and (e) PLLA/1HAx, 14 days. The inserted images were taken after 0 days, respec-
tively. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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around 690 cm'1.55,56 By comparing the FTIR-ATR results
before and after crosslinking, it is possible to observe that
no new bonds ascribed to HA crosslinking were detected
[Fig. 5(b)].33 Instead of formation of different bonds than
the bonds already present in the HA molecules, the CAOH
bonds are replaced by CAOAC bonds. However, comparing
the intensity of different peaks, the latter observation can
be confirmed. First, it is crucial to consider that during the
crosslinking reaction HA can solubilize in water, up to a cer-
tain extension, despite the presence of acetone. This
explains why all peaks have lower intensities. Nevertheless,
some observations can be performed: the HCl addition on
FTIR-ATR spectra of the uncrosslinked HA film resulted in a
clear decrease of the absorbance at 1600 cm'1, and an
increase of the absorbance at 1730 cm'1 was observed.
This change can be ascribed to the ion exchange of carboxyl
groups of HA from ACOO'Naþ to ACOOH (x) caused by the
referred HCl addition.33 Moreover, the AOH (st) peak (þ),
have a significant decrease.
It is already stated that ethanol inhibits crosslinking of
HA with GA, which suggests that hydroxyl groups of HA are
involved in the crosslinking reaction with GA, competing
with hydroxyl groups of ethanol.33 If the agent has two
aldehyde groups in one molecule like GA, the following
crosslinks will be formed between the two polyol molecules,
being also assumed that the HA crosslinking with GA gives
rise to the formation of acetals.33
X-ray photoelectron spectroscopy. To further verify the
findings from the FTIR spectra, XPS analyses of 1% HA and
HAx films were performed. Table II shows the XPS atomic
percentage of Carbon (C), Oxygen (O), and Sodium (Na) ele-
ments present in the referred samples, where it is observ-
able an increase of the values for C content when crosslink-
ing was performed. Trace elements were also detected.
Because no new elements were added to the HA struc-
ture besides the ones existing in the HA repeating units, the
GA-crosslinking reaction can be assessed by XPS. As previ-
ously highlighted, the GA-crosslinking reaction seems to
take place with the hydroxylic groups, with a replacement
of the CAOH by CAOAC groups. For that reason, and
because hydrogen cannot be measured by XPS,57 the cross-
linking reaction can be easily confirmed by observing the
difference between the C1s (C¼O) and C1s (CAO) peaks,
with the C1s (CAC, CAH) peak. Experimental results
showed that XPS was an effective technique in detecting the
subtle variation in atomic energy binding before and after
crosslinking. Figure 6 shows the complex C1s bond for the
two materials that was decomposed into Gaussian contribu-
tions, using a non-linear algorithm. The intensity of the indi-
vidual peaks is shown in Table III. The intensity of the C1s
(CAC, CAH) peak of the HAx spectra is higher for HAx.
Moreover, it is observed a slight increase on peaks 2 (CAO)
and 3 (C¼O) and a large one on peak 1 (CAC, CAH). This
provides a clear indication of the GA-crosslinking of the HA,
taking into consideration GA molecular formula,
O¼HCA(CH2)3ACH¼O.











FIGURE 5. FTIR-ATR spectra of: (a) 1% HA films and (b) 1% HAx films.
TABLE II. XPS Atomic Percentage (%) of C, O, and Na




HA 65.2% 26.3% 1.4%
HAx 69.9% 22.8% 0.4%
FIGURE 4. Detail of the thermogravimetry scans of the developed
films and scaffolds, representing relative weight versus temperature.
-n- 1% HAx, -l- PLLA, -~- PLLA/0.05HAx, -!- PLLA/0.1HAx, -^-
PLLA/0.5HAx, and -3- PLLA/1HAx.
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Mechanical analysis: Compression test. A proper mechani-
cal characterization is among the most important physical
tests that must be carried out, to evaluate if the materials
are capable to withstand mechanical stresses in clinical
use.58 The mechanical analysis will dictate the viability of
applying these materials in terms of their geometrical integ-
rity at short term, determined by the elastic modulus and
strength of the specimens to evaluate its potential as a bone
tissue substitute. Figure 7 shows a slight increase of the
elastic compression modulus (E) values with increasing HAx
concentration on the PLLA scaffolds. The E value for the
PLLA scaffolds was 23 MPa. With the HAx coating, the
determined E values are 35 MPa for the PLLA/0.5HAx scaf-
folds and 36 MPa for the PLLA/1HAx scaffolds. Only the E
values between PLLA and PLLA/0.5HAx, and between
PLLA and PLLA/1HAx scaffolds are statistically significant
FIGURE 6. XPS C1s core level spectra of: (a) 1% HA films and (b) 1% HAx films. The inserted figures correspond to the survey scan spectra of
1% HA and 1% HAx films, respectively.
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(*p < 0.05). The HA content is too small to greatly affect
the mechanical properties of the hybrid scaffold, but it can
be noted an enhancement of the stiffness of the materials
probably due to the crosslinking bonds.34,35,50,59 This data
demonstrated that the mechanical properties of the PLLA
scaffolds in the same magnitude of others possessing the
same material/processing technique and with similar poros-
ity and pore size distribution.41,60
The complexity of the architecture and the variability of
properties of bone tissue, as well as differences in age,
nutritional state, activity (mechanical loading), and disease
status of individuals establish a major challenge in fabricat-
ing scaffolds for bone TE that will meet the needs of specific
repair sites in specific patients.5,61 The cortical bone is solid
and dense, while the inner layer, cancellous bone, is a
spongy honeycombed structure filled with blood vessels and
bone marrow maximizing the strength to weight ratio for
bending and compression loads.61 The elastic modulus of
cancellous bone has values ranging from 20 to 50 MPa,61
which are similar to the obtained results. Despite the me-
chanical properties of the developed scaffolds needs to be
improved for the proposed applications, that is, cortical
bone regeneration. A strategy that has been used to accom-
plish this goal consists on the reinforcement of the PLLA
scaffolds with a ceramic material, such as hydroxyapatite.
In vitro cell culture studies
L929 adhesion, morphology, and assessment of cytotoxi-
city. The response of cells to biomaterials is often initiated
by cell contact and adhesion to the biomaterial surface.62 In
fact, cell behavior on a biomaterial depends on the surface
properties, such as roughness, topography, wettability,
charge, chemistry, and surface energy.2 In most cases, the
cell adhesion to substrates or ECM components is regulated
by specific cell surface receptors, proteins, and proteogly-
cans, which are either part of the matrix or have adsorbed
onto the surface of the biomaterials from the culture media.
The matrix adheres to the surface and cells then bind to the
matrix via those receptors.62,63 Thus, the substrate influen-
ces cell attachment, adhesion, and spreading.62
L929 adhesion and morphology were investigated by
SEM analysis after 24 h of culturing (Fig. 8). SEM micro-
graphs of L929 reveals that cells were able to adhere and
presented a flatten morphology, thus exhibiting a good ad-
hesion to all substrates, both at the surface and core of the
scaffolds. The attached cells presented a typical morphology
for fibroblasts with an elongated shape.64 The seeding of
cells onto porous PLLA normally do not provide difficulties,
especially when slow degrading PLLA is used, as it is the
case.65 Moreover, with the HA, a glycosaminoglycan, the
same is observable, even after the GA-crosslinking.
Figure 9 shows the cell viability assessed by carrying
out the MTS test after 72 h of culturing. From the results it
is possible to assess that cells are viable when cultured
onto all the scaffolds. No significant differences on the L929
cytotoxicity of the different scaffolds are detected. By its
turn, these data prove that the HA crosslinking with GA,
with the additional glycine aqueous solution treatment, do
not have any cytotoxic effect on L929 cells. Significant dif-
ferences were also observed between the tissue culture
polystyrene (TCPS) controls and the scaffolds. In addition,
cell viability of the fibroblasts on PLLA/1HAx scaffolds sig-
nificantly decreased (p < 0.05) as compared to that for
PLLA and PLLA/0.05HAx scaffolds, which suggests that
higher HA concentrations may inhibit cell viability.49 Surface
roughness enhances attachment, proliferation, and differen-
tiation of anchorage dependent bone forming cells, there-
fore, the results obtained were as expected.5 However, it
was already stated that HA concentrations influence bio-
compatibility of a biomaterial, as only HA concentrations in
certain range (0.01–0.1%) can enhance the cell adhesion,
migration, and proliferation. With HA concentrations above
0.1% it would reduce or even inhibit the effect.49 The pres-
ent results corroborate these findings.
Comparing all SEM micrographs taken after 24 h with
the ones taken after 72 h of in vitro culturing, it is notorious
that L929 cells did not obstruct the pores of the scaffold at
the surface, have perfectly adhered and grew favorably (Fig.
10). Besides spreading actively throughout all 3D scaffolds,
these cells presented a flatten morphology. As it can be eas-
ily observed in Figure 10, L929 have also proliferated better
FIGURE 7. Elastic modulus (E, MPa) of the PLLA, PLLA/0.05HAx,
PLLA/0.1HAx, PLLA/0.5HAx, and PLLA/1HAx scaffolds, obtained from
Compression Tests. Bars represent main statistical differences (n ¼ 5,
*p < 0.05) in comparison with PLLA scaffold.
TABLE III. Intensity of CAC, CAH, CAO, and C¼O peaks,
Obtained from the XPS Spectra of 1% HA and 1% HAx
Sample Peak Intensity Assignments
1% HA 21,080 CAC, CAH
10,041 CAO
4156 C¼O
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on the scaffolds surface than on its cross section, except for
areas with large and interconnected pores, even in the mid-
dle of the scaffolds, or in areas more close to the surface. It
is clear that the different pore size did not affect cell pene-
tration depth.5 Therefore, cells were able to penetrate
deeper into the scaffold core, which greatly affects the over-
all performance of the construct and shows that scaffold
architecture allowed cells in-growths and a sufficient diffu-
sion of nutrients.45 In addition, the formation of cells mico-
villi is also observed, which is suggestive of cell activation.45
These data are quite promising and future cell culture
studies combining the PLLA/HAx scaffolds and bone mar-
row stromal cells (BMSCs), for longer times of in vitro cul-
turing, are envisioned to further elucidate the potential
applications in bone TE scaffolding.
CONCLUSIONS
Bone is one of the tissues with the highest demand for regen-
eration, replacement, or reconstruction. Efforts in bone tissue
engineering (TE) have aimed at mimic the extracellular matrix
to help guide morphogenesis and tissue repair. In a step
FIGURE 9. MTS test on the PLLA, PLLA/0.05HAx, PLLA/0.1HAx, PLLA/
0.5HAx, and PLLA/1HAx constructs, to determine L929 cell viability
after culturing for 72 h. Bars represent main statistical differences
(n ¼ 3, p < 0.05). TCPS was used as control.
FIGURE 8. SEM micrographs of the surface of the different scaffolds seeded with L929 (1 " 105 cells per scaffold) after 24 h of culturing: (a)
PLLA, (b) PLLA/0.05HAx, (c) PLLA/0.1HAx, (d) PLLA/0.5HAx, and (e) PLLA/1HAx. The inserted images were taken from the cross section of the
scaffolds, respectively. It is also possible to observe that cells perfectly adhere and present a flatten morphology (*).
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forward addressing this challenge, novel poly(L-lactic acid)
scaffolds coated with glutaraldehyde-crosslinked hyaluronic
acid were developed. The crosslinking reaction was achieved
in a recognizable and stable manner. The mechanical proper-
ties of the developed scaffolds showed high potential for bone
TE. Preliminary cell culture studies showed that these scaf-
folds permitted mouse lung fibroblast cell line (L929) cells
adhesion, cells in-growth and proliferation, forming a mono-
layer onto the PLLA/HAx scaffolds. In addition, the HA cross-
linking with glutaraldehyde showed no negative effect, over
L929 cells viability in vitro. However, as already stated, HA
concentrations above 0.1% can reduce or even inhibit cells vi-
ability. Therefore, the developed glutaraldehyde-crosslinked
hyaluronic acid/poly(L-lactic acid) hybrid scaffolds showed
great promise for bone TE applications.
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